A pro-life organization is criticizing a study and accusing the media of bias.
The study by University of California-Davis, which examined the effects of abortion pill reversal, was halted early over concerns of excessive bleeding among some women who were participating.
The study was looking at the use of progesterone, which is also administered to help women avoid miscarriages.
Dr. Donna Harrison of the American Association of Pro-Life Obstetricians and Gynecologists says the study shows progesterone is not the problem.
“You've got much more likelihood of bleeding after mifepristone,” she advises, “than you do after mifepristone and progesterone.”
The claim that progesterone is more dangerous is not true, Harrison says, and she tells OneNewsNow the media should actually read the study closer.
“Because the numbers underline the safety of progesterone and the effectiveness,” she says, “and even though it's only five patients that got progesterone, four out of the five had a living baby at two weeks.”
That conforms with other information that there is up to an 80 percent chance of saving the baby if a woman changes her mind and obtains progesterone soon enough after taking the first abortion pill.